On June 20, 2017, Gregory K. Ekizian a director of Protagenic Therapeutics, Inc. and the Chairman of the Audit Committee of the company's Board of Directors notified the company that he was resigning from the Board effective immediately. Mr. Ekizian's resignation is due to compliance with restrictions imposed upon him by a new position he has taken with an unrelated company. Accordingly, Mr. Ekizian will not stand for re-election to the Board at the Company's upcoming Annual Meeting of Stockholders, which is currently scheduled to be held on July 7, 2017 at 11:00 a.m., Eastern Daylight Time, at the Company's offices in New York City. The Company plans to appoint a replacement for the position vacated by Mr. Ekizian in the near future.